title: Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL-FNBP1 fusion gene.
authors.affiliation: Department of Pediatrics, University Hospital Erlangen , Erlangen , Germany.
authors.forename: Manuela
authors.initials: M
authors.lastname: Krumbholz
authors.forename: Ronny
authors.initials: R
authors.lastname: Jung
authors.forename: Jutta
authors.initials: J
authors.lastname: Bradtke
authors.forename: Dirk
authors.initials: D
authors.lastname: Reinhardt
authors.forename: Daniel
authors.initials: D
authors.lastname: Stachel
authors.forename: Markus
authors.initials: M
authors.lastname: Metzler
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002352:Carrier Proteins / Q000235:genetics*; D003561:Cytarabine / Q000008:administration & dosage; D050556:Fatty Acid-Binding Proteins; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007223:Infant; D059785:Karyotype; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D008942:Mitoxantrone / Q000008:administration & dosage; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D002352:Carrier Proteins; C433770:FNBP1 protein, human; D050556:Fatty Acid-Binding Proteins; D015514:Oncogene Proteins, Fusion; D003561:Cytarabine; D051788:Myeloid-Lymphoid Leukemia Protein; D008942:Mitoxantrone